Cardiovascular Devices Market Scope And Analysis

  • Report Code : TIPHE100000826
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Cardiovascular Devices Market Scope, Growth, Size and Share by 2031

Buy Now


Cardiovascular Devices Market Report Scope

Report Attribute Details
Market size in 2023 US$ 54.2 Billion
Market Size by 2031 US$ 96.6 Billion
Global CAGR (2023 - 2031) 8.6%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Device
  • Electrocardiography
  • Pacemaker
  • Stent
  • Defibrillator
  • Cardiac Catheter
  • Guidewire
  • Heart Valve
  • Event Monitor
By Application
  • Coronary Heart Disease
  • Sudden Cardiac Arrest
  • Stroke
  • Cerebrovascular Heart Disease
By End User
  • Hospitals
  • Ambulatory Surgery Centers
  • Cardiac Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Medtronic
  • Boston Scientific Corporation
  • Abbott
  • Biosense Webster Inc Johnson and Johnson
  • General Electric Company
  • Koninklijke Philips N V
  • Siemens AG
  • BD
  • B Braun Melsungen AG
  • Edwards Lifesciences Corporation
  • Cardiovascular Devices Market News and Recent Developments

    The Cardiovascular Devices Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the cardiovascular devices market are listed below:

    • GE Healthcare launched its first ‘Made in India’, ‘AI-powered’ Cath lab - Optima IGS 320 to advance cardiac care in India. Built at Wipro GE Healthcare’s new factory, launched under the PLI (production-linked incentive) scheme in Bengaluru, the Cath lab leverages the GE proprietary AutoRight technology. Powered by Edison, AutoRight is the first neural network-based interventional image chain. AutoRight features Artificial Intelligence that automatically optimizes image and dose parameters in real-time, enabling clinicians to focus their attention and expertise on patients. (Source: GE Healthcare, Company Website, September 2022)

    Cardiovascular Devices Market Report Coverage and Deliverables

    The “Cardiovascular Devices Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

    • Cardiovascular devices market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Cardiovascular devices market trends as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • Cardiovascular devices market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the cardiovascular devices market
    • Detailed company profiles